Sviluppa un 'human in silico model' che integra big data multiomici e chimica quantistica per il drug discovery AI.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Series A Tres Alchemix raised 650 million yen in a Series A led by DNX Ventures with Waseda University Ventures, opening a laboratory in Oxford. | $4.2M |